Van Leeuwen & Company, LLC Eli Lilly & CO Transaction History

Van Leeuwen & Company, LLC

  • $196 Million
  • Q1 2024

A detailed history of Van Leeuwen & Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Van Leeuwen & Company, LLC holds 5,638 shares of LLY stock, worth $4.31 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
5,638
Previous 5,621 0.3%
Holding current value
$4.31 Million
Previous $3.28 Million 33.88%
% of portfolio
2.24%
Previous 1.92%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$592.2 - $792.28 $10,067 - $13,468
17 Added 0.3%
5,638 $4.39 Million
Q4 2023

Feb 07, 2024
SELL
$525.19 - $619.13 $476,347 - $561,550
-907 Reduced 13.89%
5,621 $3.28 Million
Q3 2023

Nov 09, 2023
SELL
$434.7 - $599.3 $618,143 - $852,204
-1,422 Reduced 17.89%
6,528 $3.51 Million
Q2 2023

Feb 06, 2024
BUY
$350.74 - $468.98 $498,752 - $666,889
1,422 Added 21.78%
7,950 $3.73 Million
Q2 2023

Aug 07, 2023
SELL
$350.74 - $468.98 $439,126 - $587,162
-1,252 Reduced 13.61%
7,950 $3.67 Million
Q1 2023

Feb 06, 2024
BUY
$310.63 - $364.82 $407,546 - $478,643
1,312 Added 16.63%
9,202 $3.16 Million
Q1 2023

May 08, 2023
BUY
$310.63 - $364.82 $407,546 - $478,643
1,312 Added 16.63%
9,202 $3.16 Million
Q4 2022

Feb 06, 2024
BUY
$321.55 - $374.67 $437,951 - $510,300
1,362 Added 20.86%
7,890 $2.89 Million
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $67,203 - $78,306
-209 Reduced 2.58%
7,890 $2.89 Million
Q3 2022

Nov 09, 2022
SELL
$296.48 - $337.87 $989,946 - $1.13 Million
-3,339 Reduced 29.19%
8,099 $2.62 Million
Q2 2022

Aug 11, 2022
SELL
$278.73 - $327.27 $811,104 - $952,355
-2,910 Reduced 20.28%
11,438 $3.71 Million
Q1 2022

May 12, 2022
BUY
$234.69 - $291.66 $612,071 - $760,649
2,608 Added 22.21%
14,348 $4.11 Million
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $2.64 Million - $3.28 Million
11,740 New
11,740 $3.24 Million
Q3 2020

Nov 13, 2020
SELL
$146.22 - $169.13 $2.18 Million - $2.53 Million
-14,943 Closed
0 $0
Q2 2020

Aug 03, 2020
BUY
$136.42 - $164.18 $555,775 - $668,869
4,074 Added 37.48%
14,943 $2.45 Million
Q1 2020

Apr 23, 2020
BUY
$119.05 - $147.35 $942,518 - $1.17 Million
7,917 Added 268.19%
10,869 $1.51 Million
Q4 2019

Feb 04, 2020
BUY
$106.92 - $132.43 $315,627 - $390,933
2,952 New
2,952 $388,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Van Leeuwen & Company, LLC Portfolio

Follow Van Leeuwen & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Leeuwen & Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email